Potential neurological manifestations of COVID-19: a narrative review
- 11 January 2021
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 134 (4) , 395-405
Abstract
Neurological manifestations are increasingly reported in a subset of COVID-19 patients. Previous infections related to coronaviruses, namely Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) also appeared to have neurological effects on some patients. The viruses associated with COVID-19 like that of SARS enters the body via the ACE-2 receptors in the central nervous system, which causes the body to balance an immune response against potential damage to nonrenewable cells. A few rare cases of neurological sequelae of SARS and MERS have been reported. A growing body of evidence is accumulating that COVID-19, particularly in severe cases, may have neurological consequences although respiratory symptoms nearly always develop prior to neurological ones. Patients with preexisting neurological conditions may be at elevated risk for COVID-19-associated neurological symptoms. Neurological reports in COVID-19 patients have described encephalopathy, Guillain-Barré syndrome, myopathy, neuromuscular disorders, encephalitis, cephalgia, delirium, critical illness polyneuropathy, and others. Treating neurological symptoms can pose clinical challenges as drugs that suppress immune response may be contraindicated in COVID-19 patients. It is possible that in some COVID-19 patients, neurological symptoms are being overlooked or misinterpreted. To date, neurological manifestations of COVID-19 have been described largely within the disease trajectory and the long-term effects of such manifestations remain unknown.Keywords
Funding Information
- received
This publication has 117 references indexed in Scilit:
- Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In VitroPLOS ONE, 2009
- Distant Relatives of Severe Acute Respiratory Syndrome Coronavirus and Close Relatives of Human Coronavirus 229E in Bats, GhanaEmerging Infectious Diseases, 2009
- Occurrence of delirium is severely underestimated in the ICU during daily careIntensive Care Medicine, 2009
- Delirium in Older Emergency Department Patients: Recognition, Risk Factors, and Psychomotor SubtypesAcademic Emergency Medicine, 2009
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2007
- Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndromeInternational Journal Of Clinical Practice, 2005
- Multiple organ infection and the pathogenesis of SARSJournal of Experimental Medicine, 2005
- Delirium as a Predictor of Mortality in Mechanically Ventilated Patients in the Intensive Care UnitJAMA, 2004
- The multifunctional or moonlighting protein CD26/DPPIVEuropean Journal of Cell Biology, 2003